期刊文献+

Piroxicam与NS-398对角膜新生血管抑制作用及对兔角膜上皮毒性作用的比较(英文) 被引量:3

NS-398 inhibits corneal neovascularization with lower cytotoxicity on corneal epithelial cell than Piroxicam in rabbits
下载PDF
导出
摘要 目的:比较Piroxicam(环氧化酶-1选择抑制剂)和NS-398(环氧化酶-2选择性抑制剂)对角膜新生血管的抑制作用并比较两者对角膜上皮细胞的毒性作用。方法:将含20μg脂多糖的缓释小丸植入兔角膜基质以诱导角膜新生血管。使用不同浓度的Piroxi-cam和NS-398滴眼剂滴眼,植入10d后分析角膜新生血管的面积。采用MTT法分析Piroxicam和NS-398对角膜上皮细胞的毒性作用。结果:0.01μmol/LNS-398和0.01μmol/LPiroxi-cam组兔角膜新生血管生长浓密,其它组因抑制剂的不同及浓度的不同角膜新生血管面积有不同程度的减低。在0.5,5及50μmol/L时,NS-398较Piroxicam对角膜上皮细胞的毒性低。结论:环氧化酶-1特异性抑制剂和环氧化酶-2特异性抑制剂对角膜新生血管形成均有抑制作用。相同浓度时,NS-398的抑制效果强于Piroxicam。在高浓度时NS-398较Piroxicam对角膜上皮细胞的毒性低。 AIM: To compare the inhibitive effect of Piroxicam (cyclooxygenase-1 selective inhibitor, COX-1 inhibitor) and NS-398 (cyclooxygenase-2 selective inhibitor, COX-2 inhibitor) on corneal neovascularization and their cytotoxity on corneal epithelial cells in vitro .· METHODS: Slow-release pellets containing lipopolysaccharide 20μg were prepared and implanted into the rabbit's corneal stroma near the limbus to induce neovascularization. Eye drops containing NS-398 or Piroxicam at various concentrations were applied. Ten days after the implantation of pellet, the neovascularization was examined and cytotoxicity of the two materials on corneal epithelium cells was analyzed by MTT assay.· RESULTS: In the 0.01μmol/L Piroxicam group, there was dense neovascularization. In the other groups, neovascularization decreased to different degrees, depending on the drug and concentration applied. The cytotoxicity of NS-398 was lower than that of Piroxicam at 0.5, 5 and 50μmol/L and the difference had statistical significance.· CONCLUSION: Both COX-1 and COX-2 inhibitors have inhibitive effect on corneal neovascularization. NS-398 is more inhibitive than Piroxicam at the same concentration, with toxicity less than NS-398.·
出处 《国际眼科杂志》 CAS 2004年第2期206-210,共5页 International Eye Science
关键词 NS-398 角膜新生血管 角膜上皮 药物毒性 PIROXICAM 环氧化酶选择抑制剂 cyclooxygenase inhibitor cornea neovascularization
  • 相关文献

参考文献20

  • 1Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA. Topical nepafenac inhibits ocular neovascularization. Invest Ophthalmol Vis Sci, 2003; 44(1):409-415
  • 2Holzer MP, Solomon KD, Vroman DT, Sandoval HP, Margaron P, Kasper TJ, Crosson CE. Photodynamic therapy with verteporfin in a rabbit model of corneal meovascularization. Invest Ophthalmol Vis Sci, 2003;44:2954-2958
  • 3Nakao S, Ogtata Y, Shimizu E, Yamazaki M, Furuyama S, Sugiya H. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Mo
  • 4Chen CC, Sun YT, Chen J J, Chiu KT. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pat
  • 5Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. CancerRes, 1995;55(14):3110-3116
  • 6Chen C, Chen YH, Lin WW. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology, 1999;97(1): 124-129
  • 7Li WW, Graysan G, Folkman J. Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci, 1991;32:2906-2911
  • 8Alfonso EC, Albert DM, Kenyon KR, Robinson NL, Hanninen L, D'Amico DJ. In vitro toxicity of gentamicin to corneal epithelial cells. Carnea, 1990;9(1):55-61
  • 9Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi K, Watanabe H, Tano Y,Handa H. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci, 1995 ;36(3 ):614-621
  • 10Benelli U, RossJR, NardiM, Klintworth GK. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci, 1997;38:274-282

同被引文献36

  • 1张黎,胡燕华.黄芩黄素抑制兔角膜新生血管的形成[J].眼科研究,2006,24(4):364-366. 被引量:4
  • 2Xiong-Lin FAN,Ting-He YU,Qian GAO,Wei YAO.Immunological Properties of Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Strain Expressing Fusion Protein IL-2-ESAT-6[J].Acta Biochimica et Biophysica Sinica,2006,38(10):683-690. 被引量:11
  • 3[1]McNamara DA,Harmey JH,Walsh TN,et al.Significance of angiogenesis in cancer theraphy[J].Br J Surg,1998;85:1044-1055
  • 4[2]Folkman J.Angiogenesis in cancer,vascular,rheumatoid and other disease[J].Nat Med,1995;1:27-31
  • 5[3]Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000; 407:249-257
  • 6[4]Nie D,Honn KV.Cyclooxygenase,lipoxygenase and tumor angiogenesis[J].Cell Mol Life Sci,2002;59:799-807
  • 7[5]Meade EA,Smith WL,DeWitt DL.Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs[J].J Biol Chem,1993 ;268(9):6610-6617
  • 8[6]Dannenberg AG,Altorki NK,Boyle JO,et al.Cycloo xygenase2:a pharmacological target for the prevention of cancer[J].Lancet Oncol,2001; 2 (9):544-551
  • 9[7]Zhang F,Warskwlat V,Wettstein M,et al.Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages[J].Biochem J,1995 ;312(Pt 1):135
  • 10[8]Joo YE,Rew JS,Seo YH,et al.Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer[J].J Clin Gastroenterol,2003; 37 (1):28-33

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部